screeningprotocol.This relative advantage has proven to be stable from year 7 to year 13 after the beginning of screening.Still,the disadvantages of overdiagnosis and overtreatment are the downsides of a population-based screening approach.But given the overall advantage of screening,a risk-adapted ...
High-risk patients (those with a positive family history or those of African American descent) are advised to begin screening at age 45. The decision to screen is based on the patient's preference following a thorough discussion of the benefits and limitations of PSA testing. Refer to a uro...
(10−3 nucleotides/division), we calculated that DZ populations should contain stop codons in the heavy chain variable region (Ighv) gene at frequencies of ∼4.1% when cells complete two cell cycles in that compartment, providing us with confidence that detecting such cells should be feasible...
Latner, Ann W
Several questions and answers on non-screening Prostate-Specific Antigen (PSA) covered by medicare are presented including one on checking PSA in a patient on testosterone therapy, pre-authorization for ...
liver and renal toxicity [63]. Concerning the treatment response, the assessment of treatment efficacy should be made in three domains: PSA response, radiological response, and clinical response [82]. The following paragraphs will explore the role of nuclear imaging tools in the management of PSMA...